Korean J Med > Volume 87(2); 2014 > Article
The Korean Journal of Medicine 2014;87(2):142-150.
Published online August 1, 2014.
DOI: https://doi.org/10.3904/kjm.2014.87.2.142   
Recent Guidelines on the Management of Blood Cholesterol: 2013 ACC/AHA Guidelines and 2014 NICE Draft Guidelines
Seung-Ho Hur
Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea
최신 콜레스테롤 치료 가이드라인: 2013 ACC/AHA Guideline and 2014 NICE Draft Guideline
허승호
계명대학교 의과대학 계명대학교 동산의료원 심장내과
Correspondence: 
Seung-Ho Hur, Tel: +82-53-250-7034, Fax: +82-53-250-7949, Email: shur@dsmc.or.kr
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Low-density lipoprotein (LDL) cholesterol plays a major role in the development and progression of atherosclerosis. Numerous studies have demonstrated that the management of cholesterol, mainly treated with statins, can reduce LDL cholesterol levels and improve clinical outcomes. The American College of Cardiology (ACC) and American Heart Association (AHA) recently released new guidelines that included the new concept of atherosclerotic cardiovascular disease (ASCVD) and pooled cohort equations for estimation of the 10-year ASCVD risk in individuals. Conversely, the draft National Institute for Health and Care Excellence (NICE) guideline is currently being updated following its publication in 2008. This draft guidance introduced the QRISK2 risk assessment tool for the risk of development of cardiovascular disease in the next 10 years and combined with cost effectiveness. Importantly, both guidelines suggested moderate- to high-intensity statin therapy for the primary and secondary prevention of cardiovascular disease. In this article, we focus on the new risk assessments and recommendations for the use of lipid-lowering therapy in each guideline.
Key Words: Guideline; Cholesterol; Statins; HMG-CoA; Cardiovascular diseases
주제어: 가이드라인; 콜레스테롤; 스타틴; HMG-CoA; 심혈관계 질환


TOOLS
METRICS Graph View
  • 1 Crossref
  •  0 Scopus
  • 3,692 View
  • 104 Download

Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6791    Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr                

Copyright © 2024 by The Korean Association of Internal Medicine.

Developed in M2PI

Close layer
prev next